newsfilter
← Latest News
Business Wire·

Cross Country Healthcare to be Acquired by Knox Lane in All-Cash Transaction Valued at $437 Million

  • Cross Country Healthcare, Inc. (NASDAQ: CCRN) entered a definitive agreement to be acquired by Knox Lane in an all-cash transaction valued at $437 million.
  • Knox Lane will purchase all outstanding shares of Cross Country Healthcare common stock for $13.25 per share.
  • The offer price represents a 31% premium to the closing stock price on May 6, 2026, and a 45% premium to the 90-day volume-weighted average trading price.
  • Upon completion, Cross Country Healthcare will become a privately held entity in Knox Lane's portfolio and cease trading on the Nasdaq exchange.
  • The transaction is expected to close in the third quarter of 2026, subject to stockholder approval and regulatory clearances.
  • The company will retain the Cross Country Healthcare name and brand following the acquisition.
  • BofA Securities, Inc. serves as the exclusive financial advisor to Cross Country Healthcare, while Davis Polk & Wardwell LLP acts as its legal counsel.
  • MTS Health Partners serves as the exclusive financial advisor to Knox Lane, with Kirkland & Ellis LLP acting as its legal counsel.
  • Cross Country Healthcare is a technology-driven healthcare workforce solutions provider operating the AI-powered Intellify® platform.
  • Knox Lane is a growth-oriented investment firm based in San Francisco focused on accelerating transformational growth for portfolio companies.